Literature DB >> 2779291

The physiological role of the endogenous colony forming units-spleen (CFU-S) inhibitor acetyl-N-Ser-Asp-Lys-Pro (AcSDKP).

E Frindel1, J P Monpezat.   

Abstract

The physiological role of the colony forming units-spleen (CFU-S) inhibitor Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) has been studied by observing the effects of AcSDKP deprivation. This deprivation was obtained by injecting polyclonal antiserum directed against AcSDKP into normal untreated mice in order to neutralize the endogenous inhibitor. The dramatic increase in the percentage of CFU-S in DNA synthesis as compared to controls receiving anti-KLH antiserum suggests that AcSDKP plays an important role in the maintenance of CFU-S in physiological quiescent state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779291

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

1.  The scientific bases of cancer management: at the interface between fundamental research and clinical practice.

Authors:  M Tubiana
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.

Authors:  N E Rhaleb; H Peng; X P Yang; Y H Liu; D Mehta; E Ezan; O A Carretero
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

3.  AcSDKP is down-regulated in anaemia induced by Trypanosoma brucei infection in mice.

Authors:  Janelisa Musaya; Enock Matovu; Edward Senga; Moffat Nyirenda; John Chisi
Journal:  Malawi Med J       Date:  2017-09       Impact factor: 0.875

4.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Mitigates Experimental Colitis Through Inhibition of Intestinal Mucosal Inflammatory Responses via MEK-ERK Signaling.

Authors:  Yingying Shi; Mingxia Zhou; Junkai Yan; Zizhen Gong; Jin Wu; Yuanwen Chen; Yingwei Chen
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.